 wilm tumor statu report nation wilm tumor studi committe rapid advanc understand wilm tumor WT manag laboratori clinic molecular genet research loss tumor suppressor gene short arm chromosom pathway respons develop neoplasm preconcept matern hair dye patern occup environment agent subject epidemiolog studi possibl risk factor histopatholog analys sever differ common tumor type WT rubric WT so-cal favor histolog FH anaplast form prognosi latter clinic research manag surgeri chemotherapi radiat therapi RT identif risk factor patient tumor type stage intens treatment RT low dose nation wilm tumor studi nwt patient distant metastas nwt dose chemotherapi pre- dactinomycin vincristin adriamycin adr doxorubicin adria columbu OH high-risk patient nwt combin modal therapi WT patient surviv rate aliv year treatment question identif late effect treatment refin therapi iatrogen complic minimum